Today, May 22, 2023, Cline Scientific AB (the "Company") disclosed a press release with information that the Company cannot assure that it has working capital for three months. The rules of Nasdaq First North Growth Market state that an issuer can be given observation status if there is material adverse uncertainty in respect of the issuer's financial position. With reference to the above, Nasdaq Stockholm AB decides that the shares (CLINE B, ISIN code SE0006758231, order book ID 226724) in Cline Scientific AB shall be given observation status. For further information about this exchange notice please contact Enforcement & Investigations, telephone +46 8 405 70 50.